Navigation Links
IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price
Date:2/5/2008

On February 5, 2008, the closing price of the Company's common stock was

$3.81 per share

IRVINE, Calif., Feb. 5 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI) today announced that it received a letter, dated February 4, 2008, from The NASDAQ Stock Market, notifying IDM Pharma that during the preceding 30 consecutive business days, the closing bid price of the Company's common stock had been below the $1.00 minimum bid per share required for continued listing on the NASDAQ Global Market under NASDAQ Marketplace Rule 4450(a)(5).

The NASDAQ letter dated February 4, 2008 has no immediate effect on the listing of the Company's common stock. On February 5, 2008, the closing price of the Company's common stock was $3.81 per share.

In accordance with NASDAQ Marketplace Rule 4450(e)(2), the Company will be granted 180 calendar days, or until August 4, 2008, to regain compliance with the minimum bid price requirement in accordance with NASDAQ Marketplace Rule 4450(a)(5) by maintaining a closing bid price of $1.00 per share or higher for a minimum of 10 consecutive trading days. If the Company is successful in meeting this requirement, NASDAQ will provide written notification that is has achieved compliance with the Rule. If the Company is unsuccessful in meeting the minimum bid requirement during this initial 180-day period, NASDAQ will provide notice to IDM Pharma that the Company's common stock will be delisted from the NASDAQ Global Market. If the Company receives a delisting notification, the Company may appeal to the Listing Qualifications Panel or apply to transfer its common stock to the NASDAQ Capital Market if IDM Pharma satisfies all criteria for initial listing on the NASDAQ C
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference
2. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
3. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
4. ARMSRx Tackles the New Rx Addiction -- Pharmacy Benefit Audits
5. NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
6. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
7. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
10. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
11. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Kentucky (PRWEB) May 29, 2015 On Monday, ... its newest location at 160 Frankfort Road in Shelbyville, Kentucky ... oversee all operations as well as treat patients , ... provide a more convenient , local clinic to better serve ... patients first making their experience as trouble-free as possible by ...
(Date:5/28/2015)... 28, 2015 The USC Verdugo Hills Hospital ... management for a decade with a current average healing rate ... USC and Wound Care Advantage to provide in-patient wound care. ... for a drop in the rate of hospital-acquired pressure ulcers ... is a complex undertaking that can frighten patients and caregivers ...
(Date:5/28/2015)... Success Strategies for Biosimilars Approval:, ... Webinar**, June 23, 2015 — 11:00 a.m. – ... June 23, 2015, FDAnews is offering the combined ... attorneys from the international law firm Duane Morris ... A Roadmap to the 351(k) Application Process. , ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 Three years ... new location for his Shore Vascular & Vein Center! ... the circulatory system. It is his mission to provide ... and respect. , Dr. Jeffrey Gosin is Board ... of the University of Pennsylvania and Jefferson Medical College. He ...
(Date:5/28/2015)... Ross A. Clevens, MD, FACS, Brevard’s ... Beard as the new marketing director for Clevens Face ... all marketing and promotional events for the practice. Beard ... developing compelling marketing strategies to achieve targeted results. Prior ... as guest communication manager at the Walt Disney World ...
Breaking Medicine News(10 mins):Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2
... a reservoir of information has done unimaginable wonders to industries ... ‘net’ working is the byword of the present age, with ... it comes as no surprise that the internet is being ... issues pertaining to health. ,While acknowledging that it is ...
... India Wednesday sounded a bird flu alert in all states ... of winter.// ,"We have given clear instruction to ... be in place till February next year," said Upma Chawdhry, ... states - Maharashtra, Gujarat and Madhya Pradesh - where the ...
... the green signal to launch a novel drug for the ... COX-2 inhibitor that seems to have no other side effects ... drugs used clinically for arthritis and of the same class ... as Vioxx and Bextra have reported heart problems in the ...
... Painless vaccines that could simply be stuck like a band-aid ... tested for protection against the flu and travelers’ diarrhea. ... early trials with the funding from the National Institutes of ... not just be painless; it may easily be used by ...
... pleasures beseechingly captures the focus of a man and holds ... away the first impressions indelibly in the recesses of his ... men, heterosexual women, homosexual men and bisexual women in groups ... concealed image of female nude or sexually arousing picture is ...
... spondylosis and badly treated fractures are some of the ... and are often laid up, according to orthopaedic experts ... the world with many delicate and complicated surgeries being ... orthopaedics department at the All India Institute of Medical ...
Cached Medicine News:Health News:If The World Wide Web is Your Self Proclaimed Physician, Trouble Could be Just a Click Away 2Health News:India sounds bird flu alert as migration season begins 2Health News:Skin-patch vaccines may replace injectable ones in future… 2Health News:Naked truths and Basic Instincts 2Health News:Mismanagement of fractures a major concern, say experts 2
(Date:5/28/2015)... , May 28, 2015   Eli Lilly and Company ... ) will host a webcast on June 11 to discuss ... baricitinib in rheumatoid arthritis. Data from these two trials, RA-BEACON and ... Programme for the EULAR Congress 2015 in Rome, ... from 10:00 to11:00 a.m. Eastern Daylight Time. The live audio ...
(Date:5/28/2015)... 28, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in healthcare, life science ... agreement with the fertility technologies expert Genea Biomedx, ... and helping couples create families. With this partnership, ... a global market leader in drugs for Assisted ...
(Date:5/28/2015)... CHICAGO , May 28, 2015  The ... left health plans and employer groups scrambling to ... by a major managed care plan, retail pharmacy ... United Healthcare,s $13.3 billion purchase of Catamaran, Rite ... recent announcement to purchase Omni-Care for $10 billion ...
Breaking Medicine Technology:Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3
... a global provider of comprehensive sample management solutions ... logistics and virtual sample intelligence, will host its ... May 2012 in Brussels, Belgium from 16:00 – ... Dr. Graham Hughes, Consultant in Pharmaceutical Development and ...
...  NxStage® Medical, Inc. (Nasdaq: NXTM ), ... announced that former NxStage® System One™ patient Nikolas ... following four successful years of more frequent home ... http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The freedom ...
Cached Medicine Technology:BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 3
This is a 3D transducer for endovaginal imaging in OB/GYN....
Super High Density, 120 field of view, angled handle, multi-frequency, convex endovaginal transducer....
Super High Density, 120 degree field of view, straight handle, multi-frequency, convex endovaginal transducer....
Visualize the prostate in both transverse and longitudinal planes....
Medicine Products: